Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles

Drug Development and Industrial Pharmacy

Volumn 40, Issue 1, 2014, Pages 61-65

  Haroun, Ahmed A ^a   El Halawany, N R ^a   Loira Pastoriza, C ^b   Maincent, P ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Anti inflammatory drug; Nanogels; Oral administration; Poly(hydroxy ethyl methacrylate); Polystyrene

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; GELATIN; GLUTARALDEHYDE; IBUPROFEN; PEROXYDISULFATE POTASSIUM; PHOSPHATE; POLYMACON; STYRENE;

ARTICLE; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; GELATIN; HYDROGEN-ION CONCENTRATION; IBUPROFEN; METHACRYLATES; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STYRENE; TIME FACTORS;

EID: 84887850961     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.746359     Document Type: Article

References (29)

1. Maincent P, Le Verge R, Sado P, et al. Disposition kinetics and oral bioavailability of vincamine-Loaded polyalkyl cyanoacrylate nanoparticles. J. Pharm Sci 1986;75:955-8.
2. Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 2007;117:163-70.
3. Sheik-Hassan A, Socha M, Lamprecht A, et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm 2007;344:53-61.
4. Sheik-Hassan A, Sapin A, Leroy P, et al. Composite microparticles with in vivo reduction of the burst release effect. Eur J Pharm Biopharm 2009;73:337-44.
5. Ikada Y, Tabata Y. Protein release from gelatin matrices. Adv Drug Delivery Rev 1998;31:287-301.
6. Chain YW. Novel drug delivery systems. 2nd ed. New York: Marcel Dekker; 1992.
7. Sakuma S, Hayashi M, Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 2001;47:21-37.
8. Kreuter J, ed. Nanoparticles. In: Colloidal drug delivery systems. New York: Marcel Dekker; 1994:219-342.
9. Carbone AL, Uhrich KE. Design and synthesis of fast-degrading poly(anhydride-esters). Macromol Rapid Commun 2009;30:1021-6.
10. Sakuma S, Ohshima H, Kondo TJ. Binding constants of metal cations to and hamaker constant for poly(N,N-l-lysinediylterephthaloyl) microcapsules. Colloid Interface Sci 1990;135:455-60.
11. Brigger I, Duberne, C, Couveur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Del Rev 2002;54:631-51.
12. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319-27.
13. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 2003;55:329-47.
14. Nakada Y, Fattal E, Foulquier M, Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm Res 1996;13:38-43.
15. Kuijpers AJ, Van Wachem PB, Van Luyn MJ, et al. In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron. J Biomed Mater Res 2000; 51:136-45.
16. Haroun AA, El Toumy SA. Effect of natural polyphenols on physicochemical properties of crosslinked gelatin-based polymeric biocomposite. J Appl Polym Sci 2010;116:2825-32.
17. Haroun AA, Gamal-Eldeen A, Harding DRK. Preparation, characterization and in vitro biological study of biomimetic threedimensional gelatin- montmorillonite/cellulose scaffold for tissue engineering. J Mater Sci: Mater Med 2009;20:2527-40.
18. Kuijpers AJ, Engbers GH, Krijgsveld J, et al. Crosslinking and characterization of gelatin matrices for biomedical applications. J Biomater Sci Polym Ed 2000;11:225-43.
19. Dinarvand R, Sepehri N, Manoochehri S, et al. Polylactide-coglycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomed 2011;6:877-95.
20. Stevens KR, Einerson NJ, Burmania JA, Kao WJ. In vivo biocompatibility of gelatin-based hydrogels and interpenetrating networks. Biomater Sci Polymer Edn 2002;13:1353-66.
21. Mario Y, Chakfe N, Deng X, et al. Carbodiimide cross-linked gelatin: a new coating for porous polyester arterial prostheses. Biomaterials 1995;16:1131-9.
22. Haroun AA, Migonney V. Synthesis and in vitro evaluation of gelatin/hydroxyapatite graft copolymers to form bionanocomposites. Int J Biol Macromol 2010;46:310-16.
23. Haroun AA, El-Halawany NR. Encapsulation of bovine serum albumin within b-cyclodextrin/gelatin-based polymeric hydrogel for controlled protein drug release. IRBM 2010;31:234-41.
24. Kang HW, Tabata Y, Ikada, Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999;20:1339-44.
25. Tabata Y, Morimoto K, Katsumata H, et al. Surfactant-free preparation of biodegradable hydrogel microspheres for protein release. J Bioact Compat Polym 1999;14:371-84.
26. Ferreira L, Vidal MM, Gil MH. Evaluation of poly(2-hydroxyethyl methacrylate) gels as drug delivery systems at different pH values. Int J Pharm 2000;194:169-80.
27. Arida AI, Amoro B, Jaghbir M, et al. Development of sustained release ibuprofen microspheres using solvent evaporation technique. Arch Pharm 1999;332:405-7.
28. Wolfe MM. Gastrointestinal toxicity of non steroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
29. Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloraquine phosphate. J Mater Sci: Mater Med 2006;17:345-58.